The Johns Hopkins University School of Medicine announces the annual request for applications (RFA) for the Swim Across America (SAA) Translational Cancer Research Awards. The expectation is that SAA Awards will spark synergistic interactions among investigators and catalyze scientific achievements of the highest quality and impact. Applications are sought focused on translational research that aims to translate findings in fundamental research into medical practice and meaningful health outcomes. Applications are similarly free to focus on specific organ sites or on issues that span multiple cancer types. Research projects that help address cancer healthcare disparities are encouraged. Review will be based on their potential to influence our scientific understanding of cancer and our clinical, operational, and financial management of the disease.

The Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center (SKCCC) is pleased to announce the continuation of the request for applications (RFA) for the SKCCC Cancer Research Pilot Fund. The Pilot Fund will support one year project proposals up to $100,000 direct costs. The expectation is that SKCCC Cancer Research Pilot Fund will spark synergistic interactions among investigators and catalyze scientific achievements of the highest quality and impact. Applications are welcomed from across the spectrum of fundamental, translational, clinical, and epidemiologic research. Applications are similarly free to focus on specific organ sites or on issues that span multiple cancer types. Applications will be evaluated based on their potential to influence our scientific understanding of cancer and our clinical, operational, and financial management of the disease.

This Request for Applications (RFA) is specifically for the adult Translational grant mechanism. Each invited institution may submit one nomination. Translational research is a critical part of the research continuum, advancing basic laboratory discoveries toward clinical application to improve human health. This grant is restricted to adult cancer research in the preclinical or translational space, with a focus on bench to-bedside strategies. Research on ANY adult cancer type is eligible. 

The Mary Kay Ash Foundation is a nonprofit, public foundation dedicated to advancing research on cancers that predominantly affect women – including but not limited to breast, ovarian, uterine, endometrial, and cervical cancers. Our focus is on supporting innovative translational research that bridges laboratory discoveries and clinical application, ultimately improving diagnosis, prognosis, prevention, or treatment. Each accredited, invited institution may submit one grant proposal for consideration. Awardees will receive a $100,000 grant (covering both direct and indirect costs) distributed over two annual installments.

Applications are limited to four per institution. The R50 award is specifically for clinician scientists supporting NCI-funded clinical trials research. The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional clinician scientists who want to continue to participate in the NCI clinical trials networks through leadership in the 1) development of national clinical trials, 2) implementation of NCI clinical trials in their institutions, and 3) national service to the NCI clinical trials networks through participation in the scientific review committees, monitoring committees and other activities, but not serve as principal investigators of research project grants. These clinician scientists are vital to sustaining the NCI-funded clinical trials enterprise. 

READ ELIGIBILITY COMPLETELY AND CAREFULLY BEFORE SUBMITTING FOR INTERNAL REVIEW